Stockreport

RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026 [Yahoo! Finance]

RenovoRx, Inc.  (RNXT) 
PDF LOS ALTOS, Calif., April 15, 2024 BUSINESS WIRE RenovoRx, Inc ("RenovoRx" or the "Company") (Nasdaq: RNXT) , a clinical-stage biopharmaceutical company developing novel [Read more]